BNP Paribas Financial Markets Has $15.85 Million Stock Holdings in Chemed Co. (NYSE:CHE)

BNP Paribas Financial Markets lifted its stake in Chemed Co. (NYSE:CHE) by 36.2% during the third quarter, Holdings Channel.com reports. The fund owned 26,381 shares of the company’s stock after buying an additional 7,007 shares during the period. BNP Paribas Financial Markets’ holdings in Chemed were worth $15,854,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of CHE. GAMMA Investing LLC grew its position in shares of Chemed by 34.4% in the 2nd quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock valued at $47,000 after acquiring an additional 22 shares during the period. American National Bank & Trust bought a new position in Chemed during the third quarter worth about $61,000. Mather Group LLC. increased its position in Chemed by 60.5% during the second quarter. Mather Group LLC. now owns 183 shares of the company’s stock worth $99,000 after buying an additional 69 shares during the last quarter. Quarry LP raised its stake in Chemed by 721.7% in the second quarter. Quarry LP now owns 189 shares of the company’s stock valued at $103,000 after buying an additional 166 shares during the period. Finally, Sound Income Strategies LLC acquired a new stake in shares of Chemed in the third quarter valued at approximately $201,000. Institutional investors own 95.85% of the company’s stock.

Insiders Place Their Bets

In other Chemed news, Director George J. Walsh III sold 400 shares of Chemed stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $597.47, for a total value of $238,988.00. Following the completion of the transaction, the director now directly owns 3,046 shares of the company’s stock, valued at $1,819,893.62. The trade was a 11.61 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $598.81, for a total value of $1,197,620.00. Following the sale, the chief executive officer now directly owns 103,735 shares in the company, valued at approximately $62,117,555.35. This trade represents a 1.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 6,845 shares of company stock worth $3,978,798 in the last quarter. 3.32% of the stock is currently owned by corporate insiders.

Chemed Stock Up 0.2 %

Shares of NYSE:CHE opened at $572.39 on Friday. Chemed Co. has a 12-month low of $523.33 and a 12-month high of $654.62. The business has a 50 day moving average of $578.27 and a 200-day moving average of $565.09. The stock has a market cap of $8.61 billion, a PE ratio of 28.96, a P/E/G ratio of 2.42 and a beta of 0.46.

Chemed (NYSE:CHE) last released its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.76 by ($0.12). The firm had revenue of $606.18 million during the quarter, compared to the consensus estimate of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The business’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same quarter last year, the firm earned $5.32 earnings per share. Equities research analysts expect that Chemed Co. will post 21.43 earnings per share for the current year.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Monday, November 18th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.35%. The ex-dividend date of this dividend is Monday, November 18th. Chemed’s dividend payout ratio is 10.11%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the company. Royal Bank of Canada dropped their price target on Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 5th. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a report on Saturday.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.